Phrontline Biopharma
Recent Finacing
Pre-Series A+
Recent Raise
$60M
Phrontline Biopharma is a Shanghai- and Suzhou-based biotech developing next-generation bispecific and dual-payload antibody-drug conjugates (ADCs) for cancer.
Recent Finacing
Recent Raise
Phrontline Biopharma is a Shanghai- and Suzhou-based biotech developing next-generation bispecific and dual-payload antibody-drug conjugates (ADCs) for cancer.
